المؤلفون: Yang C; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China., Ma S; Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China., Zhang J; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China., Han Y; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China., Wan L; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China., Zhou W; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China., Dong X; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China., Yang W; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China., Chen Y; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China., Gao L; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China., Cui W; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China., Jia L; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China., Yang J; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China., Wu C; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China., Wang Q; Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China., Wang L; Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.; Division of Drug Screening and Biology Evaluation, Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Benxi 117004, China.

المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jun 04; Vol. 121 (23), pp. e2317790121. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/genetics , Lung Neoplasms*/metabolism , Lung Neoplasms*/pathology , Lung Neoplasms*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/metabolism , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Erlotinib Hydrochloride*/pharmacology , Cell Transformation, Neoplastic*/genetics, Humans ; Animals ; Mice ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Drug Resistance, Neoplasm/genetics ; Wnt Signaling Pathway/genetics ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Protein Kinase Inhibitors/pharmacology ; Xenograft Model Antitumor Assays ; Small Cell Lung Carcinoma/genetics ; Small Cell Lung Carcinoma/metabolism ; Small Cell Lung Carcinoma/pathology ; Transcription, Genetic ; Histocompatibility Antigens ; Histone-Lysine N-Methyltransferase

المؤلفون: Tomic K; Department of Oncology, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina., Krpina K; Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia., Baticic L; Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Rijeka, Rijeka, Croatia., Samarzija M; Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia., Vranic S; College of Medicine, QU Health, Qatar University, Doha, Qatar.

المصدر: Journal of drug targeting [J Drug Target] 2024 Jun; Vol. 32 (5), pp. 499-509. Date of Electronic Publication: 2024 Mar 25.

نوع المنشور: Journal Article; Case Reports; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2330 (Electronic) Linking ISSN: 10267158 NLM ISO Abbreviation: J Drug Target Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/drug therapy , ErbB Receptors*/genetics , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Lung Neoplasms*/drug therapy , Small Cell Lung Carcinoma*/genetics , Small Cell Lung Carcinoma*/pathology, Humans ; Drug Resistance, Neoplasm ; Immunotherapy/methods ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology

المؤلفون: Cooke SA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Belderbos JSA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands. Electronic address: J.belderbos@nki.nl., Reymen B; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Lambrecht M; Department of Oncology, Experimental Radiation Oncology, KU Leuven - University of Leuven, Leuven, Belgium; Department of Radiotherapy-Oncology, University Hospitals Leuven, Gasthuisberg, Belgium., Fredberg Persson G; Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Faivre-Finn C; Department of Clinical Oncology, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK., Dieleman EMT; Department of Radiation Oncology, Location AMC, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., van Diessen JNA; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Sonke JJ; Department of Radiation Oncology, Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., de Ruysscher D; Department of Radiation Oncology (MAASTRO Clinic), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul; Vol. 196, pp. 110312. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Patient Reported Outcome Measures* , Quality of Life*, Humans ; Male ; Female ; Middle Aged ; Aged ; Neoplasm Staging ; Radiotherapy Dosage ; Chemoradiotherapy/adverse effects ; Positron-Emission Tomography

المؤلفون: Asano Y; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8641, Japan., Hayashi K; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8641, Japan. Electronic address: hysk@med.kanazawa-u.ac.jp., Takeuchi A; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8641, Japan., Kato S; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8641, Japan., Miwa S; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8641, Japan., Taniguchi Y; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8641, Japan., Okuda M; Department of Radiology, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8640, Japan., Matsumoto I; Department of Thoracic Surgery, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8640, Japan., Yano S; Department of Respiratory Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641, Japan., Demura S; Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8641, Japan.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Jul 30; Vol. 136, pp. 112276. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/blood , Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/mortality , Lung Neoplasms*/drug therapy , Lung Neoplasms*/blood , Immune Checkpoint Inhibitors*/therapeutic use , Bone Neoplasms*/secondary , Bone Neoplasms*/drug therapy , Bone Neoplasms*/blood , Biomarkers, Tumor*/blood , C-Reactive Protein*/analysis , Neutrophils*/immunology, Humans ; Female ; Male ; Middle Aged ; Aged ; Prognosis ; Inflammation/blood ; Nutrition Assessment ; Aged, 80 and over ; Adult ; Retrospective Studies

المؤلفون: Zhang L; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China., Xu Y; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China., Cheng Z; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China., Zhao J; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China; Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China., Wang M; Department of Public Laboratory, Tianjin Medical University Cancer Institute & Hospital, 300060, Tianjin, China., Sun Y; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China., Mi Z; Department of Public Laboratory, Tianjin Medical University Cancer Institute & Hospital, 300060, Tianjin, China; Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China. Electronic address: mizeyun@tmu.edu.cn., Yuan Z; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China. Electronic address: zyuan@tmu.edu.cn., Wu Z; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China; Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China. Electronic address: zwu08@tmu.edu.cn.

المصدر: Cancer letters [Cancer Lett] 2024 Jul 28; Vol. 595, pp. 217000. Date of Electronic Publication: 2024 May 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

مواضيع طبية MeSH: MicroRNAs*/genetics , MicroRNAs*/metabolism , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/metabolism , Ferroptosis*/genetics , NF-E2-Related Factor 2*/genetics , NF-E2-Related Factor 2*/metabolism , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/metabolism , Radiation Tolerance*/genetics , Early Growth Response Protein 1*/genetics , Early Growth Response Protein 1*/metabolism , Signal Transduction* , Gene Expression Regulation, Neoplastic*, Humans ; Animals ; Cell Line, Tumor ; Mice ; Male ; Reactive Oxygen Species/metabolism ; A549 Cells ; Mice, Nude ; Female

المؤلفون: Patil BR; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Bhadane KV; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Ahmad I; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Agrawal YJ; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Shimpi AA; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Dhangar MS; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India., Patel HM; Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 4254, India. Electronic address: hpatel_38@yahoo.com.

المصدر: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Jul 15; Vol. 109, pp. 117796. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3391 (Electronic) Linking ISSN: 09680896 NLM ISO Abbreviation: Bioorg Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Acrylamides*/chemistry , Acrylamides*/pharmacology , Aniline Compounds*/chemistry , Aniline Compounds*/pharmacology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , ErbB Receptors*/antagonists & inhibitors , ErbB Receptors*/metabolism , ErbB Receptors*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Protein Kinase Inhibitors*/chemistry , Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/chemical synthesis , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemical synthesis , Mutation*, Humans ; Structure-Activity Relationship ; Molecular Structure ; Piperazines/chemistry ; Piperazines/pharmacology ; Indoles ; Pyrimidines

المؤلفون: Wisnivesky JP; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Mudd J; Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Stone K; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Slatore CG; Division of Pulmonary & Critical Care Medicine, Department of Medicine, and Department of Radiation Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Center to Improve Veteran Involvement in Care, Veterans Affairs (VA) Portland Health Care System, Portland, Oregon, USA.; Section of Pulmonary & Critical Care Medicine, VA Portland Health Care System, Portland, Oregon, USA., Flores R; Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Swanson S; Department of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Blackstock W Jr; Department of Radiation Oncology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA., Smith CB; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Chidel M; Department of Radiation Oncology, Colorado Permanente Medical Group, Denver, Colorado, USA., Rosenzweig K; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Henschke C; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Kern JA; Division of Medical Oncology, Department of Medicine, National Jewish Health, Denver, Colorado, USA.

المصدر: Cancer [Cancer] 2024 Jul 15; Vol. 130 (14), pp. 2515-2527. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/surgery , Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/psychology , Quality of Life* , Radiosurgery*/methods , Lung Neoplasms*/surgery , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Lung Neoplasms*/psychology , Pneumonectomy*/methods, Humans ; Male ; Female ; Aged ; Middle Aged ; Neoplasm Staging ; Longitudinal Studies ; Treatment Outcome ; Aged, 80 and over ; Thoracic Surgery, Video-Assisted/methods

المؤلفون: Cittolin-Santos GF; Division of Oncology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA., Knapp B; Division of Oncology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA., Ganesh B; Departments of Medicine and Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Gao F; Division of Public Health Science, Department of Surgery, Washington University in St Louis School of Medicine, St Louis, Missouri, USA., Waqar S; Division of Oncology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA., Stinchcombe TE; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA., Govindan R; Division of Oncology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA., Morgensztern D; Division of Oncology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.

المصدر: Cancer [Cancer] 2024 Jul 15; Vol. 130 (14), pp. 2453-2461. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Small Cell Lung Carcinoma*/epidemiology , Small Cell Lung Carcinoma*/mortality , Small Cell Lung Carcinoma*/pathology , Lung Neoplasms*/epidemiology , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , SEER Program*, Humans ; Female ; Male ; Middle Aged ; Aged ; Incidence ; United States/epidemiology ; Neoplasm Staging ; Adult ; Aged, 80 and over ; Survival Rate

المؤلفون: Bossé Y; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada; Department of Molecular Medicine, Université Laval, Quebec City, Canada. Electronic address: yohan.bosse@criucpq.ulaval.ca., Dasgupta A; Oncology Data Science, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Abadier M; Translational Medicine Early Oncology, AstraZeneca, Waltham, MA, USA., Guthrie V; Oncology Data Science, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Song F; Translational Medicine Early Oncology, AstraZeneca, Munich, Germany., Saavedra Armero V; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada., Gaudreault N; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada., Orain M; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada., Lamaze FC; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada., Melton C; GRAIL, LLC, Menlo Park, CA, USA., Nance T; GRAIL, LLC, Menlo Park, CA, USA., Hung T; GRAIL, LLC, Menlo Park, CA, USA., Hodgson D; Translational Medicine Early Oncology, AstraZeneca, Cambridge, United Kingdom., Abbosh C; Translational Medicine Early Oncology, AstraZeneca, Cambridge, United Kingdom., Joubert P; Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada; Department of Molecular Biology, Pathology and Medical Biochemistry, Université Laval, Quebec City, Canada.

المصدر: Cancer letters [Cancer Lett] 2024 Jul 10; Vol. 594, pp. 216984. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/surgery , Carcinoma, Non-Small-Cell Lung*/blood , Carcinoma, Non-Small-Cell Lung*/pathology , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Lung Neoplasms*/surgery , Lung Neoplasms*/genetics , Lung Neoplasms*/blood , Lung Neoplasms*/pathology , DNA Methylation* , Neoplasm Staging*, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Prognosis ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/genetics

المؤلفون: Igata F; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan., Inoue H; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan hinoue@fukuoka-u.ac.jp., Ikeda T; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan., Nakao A; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan., Ebi N; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan., Fujita M; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.

المصدر: Anticancer research [Anticancer Res] 2024 Jul; Vol. 44 (7), pp. 3175-3183.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Small Cell Lung Carcinoma*/drug therapy , Small Cell Lung Carcinoma*/pathology , Small Cell Lung Carcinoma*/mortality , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antibodies, Monoclonal*/adverse effects , Antibodies, Monoclonal*/administration & dosage , Antibodies, Monoclonal*/therapeutic use, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Aged, 80 and over ; Treatment Outcome ; Adult ; Neoplasm Staging